The healthcare industry including Jasper Therapeutics experiences a sharp surge in the value of the stock by increasing 21% today. More importantly, the weekly chart displays a huge soar of 90%. Prices historically jumped from $7.70 to $17.41, accounting for $7.05 gains in a week. It influences the monthly statistics, therefore, it shows a jump of 49.65%. It is clear that the company tries to recover the value from the abrupt dip on October 12. Before that day, the company was holding a stable mark at $9.98.
Currently, a majority of analysts recommend focusing on JSPR stock, because the company has the potential to have a gradual surge in perspective times. Jasper Therapeutics represents itself as a clinical-stage healthcare company based on the treatment of patients with hematopoietic stem cell medicine. Jasper Therapeutics also concentrates on the investigations of new treatments of patients to ensure the wider use of stem cell transplantation and ex vivo gene therapy